Involvement of tumor necrosis factor-? receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation
Authors:
- Hirotaka TashiroHTHirotaka Tashiro
- Toshiyuki ItamotoTIToshiyuki Itamoto
- Hideki OhdanHOHideki Ohdan
- Kouji ArihiroKAKouji Arihiro
- Yuko TateakiYTYuko Tateaki
- Hideki NakaharaHNHideki Nakahara
- Makoto OchiMOMakoto Ochi
- Hiroshi HinoHHHiroshi Hino
- Kazuyuki MizunumaKMKazuyuki Mizunuma
- Hidetaka HaraHHHidetaka Hara
- Daisuke TokitaDTDaisuke Tokita
- Takashi OnoeTOTakashi Onoe
- 16 October 2004
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 17 (10) , 626-633
Abstract
The pathway leading to cell death in clinical liver transplantation is not known. Eight liver transplant recipients and eight donors were enrolled in this study. Postoperative serum levels of alanine transferase had significantly increased in the recipients compared with those in the donors. Mild centri-lobular necrosis was observed in only liver tissues taken from the recipients. Tumor necrosis factor (TNF)-R1 and death receptor 5 expression levels had increased in liver tissues taken from the recipients. There were no changes in the levels of Fas/Fas ligand expression in liver tissues from either the donors or recipients. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression was down-regulated in donor liver after hepatectomy and liver allograft after implantation. The results suggest that, although ischemic liver injury was not serious, due to the short ischemia time, TNF and TRAIL signals are associated with liver ischemic injury in live-donor liver transplantation but Fas signal is not.Keywords
This publication has 33 references indexed in Scilit:
- Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the LiverJournal of Virology, 2002
- Cholestasis Increases Tumor Necrosis Factor-Related Apoptotis-Inducing Ligand (TRAIL)-R2/DR5 Expression and Sensitizes the Liver to TRAIL-Mediated CytotoxicityThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Mechanism of Cell Death During Warm Hepatic Ischemia–Reperfusion in Rats: Apoptosis or Necrosis?Hepatology, 2001
- Death Receptors: Signaling and ModulationScience, 1998
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Involvement of Platelet–Activating Factor in Cytokine Production and Neutrophil Activation After Hepatic Ischemia–ReperfusionHepatology, 1996
- Fas antigen expression in liver tissues of patients with chronic hepatitis BJournal of Hepatology, 1996
- Ischaemia-reperfusion injuryBritish Journal of Surgery, 1994
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.Journal of Clinical Investigation, 1990